Brain Sciences Events Announce Your Event Here

No upcoming events

12–15 February 2012 4th International Conference on Drug Discovery and Therapy

Dubai, UAE

This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments in drug discovery and on new therapeutics.

This conference organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, focuses on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.

After the overwhelming success of the previous conferences held in Dubai in February 2008, 2010 and 2011 (where many Nobel Laureates attended), the fourth conference promises to be a much larger event with over 500 talks delivered and 36 thematic sessions with poster presentations and an associated commercial exhibition.

Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international pharmaceutical, academic and clinical communities.

3–4 October 2017 4th International Neurotech Investing and Partnering Conference

Geneva, Switzerland

Entering its fourth year, the International Neurotech Investing and Partnering Conference is the premier forum for the neurotechnology industry. Spanning pharmaceuticals, medical devices, software, and diagnostics for use in neuroscience, this global forum gathers investors, executives, entrepreneurs, and scientists to shape the future of their organizations and the field.

Organized by the Neurotechnology Industry Organization and Cambridge Innovation Institute, the fourth International conference will be held 3 - 4 October 2017 at the Wyss Center for Bio and Neuroengineering in Geneva, Switzerland.

This market-defining event features keynotes on the state of the neurotech industry worldwide, cutting edge company presentations, leading translational research projects, and panel discussions on a comprehensive selection of neurobiology topics.

You'll get a first-hand glimpse of what's in the pipeline

Find out about new product licensing and partnering opportunities
Learn what venture and strategic investors are looking for
Discover emerging technologies and companies
Hear about cutting edge translational research and funding opportunities
Plan networking and schedule meetings ahead of time with other attendees

1–2 May 2018 13th the Neurotech Investing & Partnering Conference

Boston, MA, USA

Now in its 13th year, the Neurotech Investing & Partnering Conference is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients.

Organized by the Neurotechnology Industry Organization and Cambridge Innovation Institute, the 13th annual conference will be held May 1-2, 2018 at the Renaissance Waterfront Hotel in Boston, MA.

The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.

4–6 May 2018 PSG Annual Meeting & Symposium

Jersey City, NJ, USA

We are happy to report that we have rescheduled the PSG Annual Meeting & Symposium for Friday, May 4-Sunday, May 6, 2018 at the Hyatt Regency Hotel in Jersey City, NJ. We are partnering with the Parkinson’s Foundation during their Center Leadership Conference. Agenda planning is in preliminary stages. Please check back here soon for more complete details.
Our opening reception on Friday, May 4, will be followed by the first meeting with our Symposium on Saturday, May 5, at 8:00 a.m. The PSG annual meeting with the PSG General Session with take place that afternoon. Activities on Sunday, May 6, will start at 8:00 a.m. with more study-specific meetings and working group meetings. Events will wrap up by 2:00 p.m. on Sunday.
Registration and lodging will open after the formal invitations go out.
We sincerely hope you can attend.

1–6 July 2018 WCP 2018-18th World Congress of Basic and Clinical Pharmacology

Kyoto, Japan

On behalf of the Japanese Pharmacological Society (JPS) and the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT), I cordially invite you to the 18th World Congress of Basic and Clinical Pharmacology (WCP2018) to be held from July 1 to 6, 2018, in Kyoto, Japan. The main theme of WCP2018 is “Pharmacology for the Future Science, Drug Development and Therapeutics.”

We are now witnessing huge waves of revolutionary changes in biomedical sciences such as individual genome sequencing, stem cell biology including iPS cells, structural biology, nanotechnology and systems biology. It is the tradition of pharmacology to take all the elements in other disciplines of science to carry out our science as in the old saying, “a pharmacologist is a jack of all trades.” We intend to organize, in collaboration with our neighboring national societies, a variety of scientific programs that allow exposure of participating pharmacologists to these new waves of science.

We believe such scientific interactions will facilitate interdisciplinary studies among life sciences and medicine that will serve human health. Emphasis will also be given to the scientific programs related to drug development and therapeutics, where researchers from academia interact with those from industry so that we together fulfill our time’s needs for innovation.

Besides science, WCP2018 will provide you a rare chance to experience old Japanese culture. Kyoto was the capital of Japan for over 1,000 years and still remains the heart of culture in Japan. Shrines, temples and historical sites in Kyoto have remained the same for centuries. Visit one of these spots and meditate there; you will feel the breath of many hundred-years of culture.

Getting off the beaten path and exploring some of the hidden areas of Kyoto will surely yield further rewards to you. July in Kyoto is the summer festive season. The Gion Festival goes on for the entire month of July and is one of the most famous festivals in Japan. It dates back to the year 869, when the people were suffering from plague and pestilence and started this festival to get rid of these maladies. It is therefore a good time to have the Pharmacology Congress and we sincerely look forward to seeing you at WCP2018 in Kyoto.

Shuh Narumiya

12–15 September 2018 HAL 2018

Otto von Guericke University Magdeburg

On behalf of the organising committee of the “International conference on healthiness and fitness across the lifespan” (HAL 2018) at the Otto von Guericke University Magdeburg, and on behalf of the European Group for Research into Elderly and Physical Activity (EGREPA) we would like to invite you to an important scientific event in Magdeburg.

Technical advances over the last few years have inspired researchers to test and validate earlier theories of motor and mental development, learning and age-related functional decline.

Physical activity has been suggested to be one of the most important factors for increasing motor and mental abilities in childhood and for promoting fitness and healthiness across the life span. Also lifestyle factors, healthy eating and physical activity, may counteract the progression of age-related cognitive, physical and neurophysiological deficits. The conference offers an opportunity for scientists from different fields such as sport and health science, neuroscience, medicine, physiology, nutrition, gerontology, cognitive science but also for teachers, clinicians, and practitioners to present new findings and to engage in discussions relevant to the topic of “healthiness and fitness across the life span”. It is an unprecedented challenge to explore the processes of motor and mental development and to cooperate across disciplines in order to recommend successful strategies.

The conference includes keynotes, working groups with introductory presentation, invited symposia, poster sessions, practical exercises, and demonstrations.

We hope you will enjoy the conference and you will find stimulating input for your own future research and work.

27–30 September 2018 18th WPA World Congress of Psychiatry

Mexico City, Mexico,

Join us in Mexico City, Mexico, 27-30 September 2018 to discuss how psychiatry can impact some of the most important social challenges facing communities across the globe.
Hear from world experts and share in research and learnings that can be applied across borders for local benefit.
Now, more than ever, it is essential for the psychiatric community to stand firm for mental health.

7–11 October 2018 the 46th Annual Meeting of the International Society for Pediatric Neurosurgery

Tel Aviv, Israel

On behalf of the annual ISPN Meeting, it is our pleasure to invite you to the 46th Annual Meeting of the International Society for Pediatric Neurosurgery taking place in Tel Aviv on 7-11 October 2018.

The pediatric neurosurgical community has grown in the last 46 years. Many national pediatric societies and groups have been founded and have joined the ISPN. Today, our annual meeting hosts over 600 delegates from all over the world.

Our practice is dynamic and has changed greatly over the course of 46 years: The 2018 meeting in Tel Aviv will reflect on these topics and breakthroughs that affect our daily dilemmas as care providers.

While embracing these changes and developments, we still preserved one very important feature: Our close-knit community. The ISPN annual meeting is the highlight of the year for pediatric neurosurgeons, where we build knowledge, meet new colleagues and form world-wide collaborations.

You are invited to a very special region of the world, where you will find a historic mixture of cultures, including the spiritual atmosphere of Nazareth and Jerusalem, and the free spirit of Tel Aviv. Israel is a unique mix of the ancient and the modern; from archaeological sites to start-ups, from top-notch museums to walking on the beach, from street food to gourmet food. It is an experience like no other.

We look forward to welcoming you to Tel Aviv to enjoy a program led by academic excellence and enriched by invigorating social elements.

Prof. Shlomi Constantini

Chair of the 46th Annual Meeting of the ISPN
Director of the Department of Pediatric Neurosurgery
Dana Children's Hospital, Tel Aviv Medical Center

9–11 October 2018 10th International Symposium on Neuroprotection and Neurorepair

Dresden (Radebeul), Germany

Dear Colleagues and Friends,

We cordially invite you to join us for the 10th International Symposium on Neuroprotection and Neurorepair (ISN&N), which will take place from October 09 to October 11, 2018.

The anniversary ISN&N meeting will take place in the vineyards of Radebeul, a quaint town at the gates of the baroque City of Dresden. Dresden has been the residence of the Saxon kings for centuries, and has a strong and rich cultural and academic history. Situated at the banks of the Elbe river, Dresden is considered one of Germany’s nicest and prosperous cities.

In continuation of the successful past meetings with up to 400 participants, the scientific focus of the 10th ISN&N will be on cerebral ischemia and brain hemorrhage, neurotrauma, neurodegeneration as well as related disciplines. Together, we will learn about and discuss the most recent and exciting findings from fundamental and translational neuroscience, as well as diagnostic and therapeutic developments.

The 10th ISN&N will provide a strong platform for contributions from the audience. Minisymposia organized by participants and ample oral presentation from delegates will accompany the key note presentations by outstanding international speakers. The 10th ISN&N will also feature ample time for discussions and scientific exchange.

We are currently setting up an exciting program for you, which will soon become available online!

Please regularly browse our homepage or join our newsletter to learn about the latest and updates. We do look forward to welcome you in Leipzig!

With warmest regards,

Johannes Boltze, MD, PhD
Chair of the Organizational Committee

2–6 November 2018 Joint Global Neurofibromatosis Conference 2018

Paris, France

Come join us to the joint global neurofibromatosis conference in Paris, from the 2nd to 6th November 2018 at the Maison de la Chimie in Paris! This conference will combine the 18th European Neurofibromatosis Meeting, the 2018 NF Conference and the 2018 Schwannomatosis & NF2 State of the Art. 800 researchers, clinicians and physicians from all the world are expected to share their knowledge about neurofibromatosis diseases.

A rich scientific program: The conference will feature the following keynote speakers:

  • Paolo G. Casali, MD, Milan, Italy
  • Mark E. Davis, PhD, Los Angeles, California, USA
  • Kristjan Jessen, PhD, London, United Kindgdom
  • Yves Levy, MD, PhD, Paris, France
  • Pier Paolo Pandolfi, MD, PhD, Boston, USA
  • Danny Reinberg, PhD, New York, USA
  • George C. Reisman Boston, USA
  • Caroline Robert Villejuif, France

EUMS Accreditation: The conference organizers will be seeking approval from the European Association Council for Continuing Medical Education in Brussels (EACCME), an institution of the UEMS, to provide EACCME credits for the attendance at the scientific sessions.
EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). Details will be available on the meeting website as soon as possible.


  • Opening of registration & abstracts submissions: January 2018
  • Abstracts submission deadline: 16th July 2018
  • Early registration fee deadline: 16th September 2018
  • Opening of the conference: 2nd November 2018

3–5 September 2010 Drugs, Psychiatric Disorders and Neurogenesis - EBPS Workshop

Tours, France

European Behavioural Pharmacology Society workshop. New perspectives on the role of neurogenesis in the mode of action of psychotropic drugs in the treatment of psychiatric diseases.

Keynote Speaker:
René Hen – Columbia University, New York, USA

11–15 September 2010 XVIIth International Congress of Neuropathology

Salzburg, Austria

Neuropathology continues to be the core discipline in research on diseases of the nervous system, linking basic and clinical neurosciences in diagnosis and research. Every 4 years, the global event of an ICN brings together the research and medical-diagnostic aspects of the field in one place. On this occasion, neuropathology is presented to the world as an indispensable and dynamic medicoscientific discipline. ICN 2010 is expected to attract a high-quality attendance of up to some 1,000 researchers, medical specialists and industry representatives. Remarkable advances in the neurosciences ensure that ICN 2010 will be a meeting of greatest interest and cutting-edge scientific reports in addition to high-level professional education. In the tradition of previous successful ICNs, there will be an outstanding list of Plenary Speakers on the most important topics, including a special Key Note Address, comprehensive Symposia, Workshops on controversial issues, and debate fora on the plethora of original inputs from Poster Presentations.

ICN 2010 will be held immediately in sequence to PRION 2010 (Sept. 8-11, 2010 -, the global forum for research on prion diseases, at the same venue. This allows for the unique opportunity to have a joint meeting between both events on Sept. 11, with top-class symposia and lectures on transmissible and non-transmissible dementias.

1–4 October 2010 6th International Symposium on Neuroprotection and Neurorepair

Rostock, Germany

Main Topics:
  • Cell death, regeneration and recovery
  • Inflammation and stroke
  • Imaging and cell tracking in stroke research
  • Stem cells and stroke therapy
  • Endogenous regeneration – can the brain really cure itself?
  • The haunted hedge – why is gliosis so important?
  • Regulatory molecules, ncRNA and metabolism – new targets for neuroprotection?
  • Mitochondria as cellular targets for protection

28–31 October 2010 The 4<sup>th</sup> World Congress on Controversies in Neurology (CONy)

Barcelona, Spain

  • Since its launch in 2007, CONy has become established as a unique meeting where physicians can meet with outstanding experts in all neurology fields, and be updated on the most pressing clinical questions of the day.
  • CONy is a true educational experience that provides the audience insight into major changes in the rapidly evolving field of neurology and clinical neuroscience.
  • The program at CONy Congresses is designed to provide an effective forum for discussing and debating unresolved issues by allowing ample time for speakers/audience discussion.
  • CONy is the only Congress of its kind that focuses mainly on controversial issues in form of debates.

29 January–1 February 2012 32nd Annual Meeting of the Australian Neuroscience Society

Gold Coast, Australia

The scientific program will run for 3 full days from Monday, 29 January to Wednesday, 1 February 2012. There will be 4 Plenary Lectures and 13 Symposia (including the Presidential Symposium), featuring outstanding overseas and Australian speakers.

22–23 February 2012 8th Annual Update Symposium Series on Clinical Neurology and Neurophysiology 2012

Tel Aviv, Israel

Two day course provides an update of selected topics in neurology and clinical neurophysiology. This course is suitable for neurologists, neuroscientists, and general internists, gerontologists, psychiatrists and physiatrists, anesthesiologists and allied health professionals with a particular interest in patients with neurological disorders who wish to update their knowledge of the mechanisms and treatments of these disorders, and to improve their expertise in clinical neurophysiology as practiced in their private offices. A professional exhibition for the industry (pharmaceutical and imaging equipment) will take place adjacent to the conference halls.

1–3 March 2012 The International Conference on Heart & Brain

Paris, France

Heart & Brain 2012 is a groundbreaking partnership of leading cardiologists and neurologists who will convene for the first time to explore the critical relationship between the heart and the brain. With the exhilarating beauty of Paris as a backdrop, participants will forge a definitive dialogue on this integrated approach and discuss the latest treatment methods in this field. According to Congress Co-Chairman Prof. Natan Bornstein, "The basic concept behind this congress is the consolidation of a hybrid field - neurocardiology or cardio-neurology: the strokologist will teach the cardiologist about the brain and the neurologist will learn how the heart is affecting the brain."

2–5 March 2012 7th International Symposium on Neuroprotection and Neurorepair

Potsdam, Germany

It is our pleasure to kindly invite you to the 7th International Symposium on Neuroprotection and Neurorepair. Internationally renowned experts in the field of stroke as well as Parkinson’s and Alzheimer’s disease will address recent scientific findings in key note lectures. The symposium will also give young scientists the opportunity to present their data and findings. Intensive scientific discussions will be facilitated by the stimulating environment of one of Germany’s most renowned former Zeppelin airship ports.

6–7 March 2012 The 2nd Annual Traumatic Brain Injury Conference

Washington, DC, USA

The 2nd Annual Traumatic Brain Injury Conference will address the challenges and opportunities in the development of new diagnostics and therapeutics for traumatic brain injury (TBI). Additionally, this conference will highlight strategies for clinical assessment of TBI and will address chronic outcomes of TBI, including post-traumatic stress disorder and neurodegeneration.

Speakers from academia, industry, the military and government will be addressing traumatic brain injury from a variety of perspectives in order to provide attendees with a holistic perspective on the diagnosis, treatment and outcomes associated with traumatic brain injury. To this end, presenters will be addressing the following issues:

  • Advances in neuroimaging for TBI
  • Clinical trial design for new TBI therapeutics
  • Implementation of biomarkers for stratification, outcome prediction and therapeutics intervention monitoring
  • Pre-clinical modeling and translating results to the clinic
  • Drug delivery (blood-brain barrier) challenges facing development of new therapies
  • Treatment of actute as well as post-acute/chronic neurorehabilitation
  • Halting secondary injury in TBI
  • Cell therapy potential for TBI
  • Cognitive measures of TBI and outcomes
  • Neuroprotection as a therapeutic intervention
  • Regulatory perspectives on clinical trials and companion diagnostic development and commercialization

16–19 May 2012 7th World Congress for NeuroRehabilitation

Melbourne, Australia

The7th World Congress for NeuroRehabilitation will be a major event in Melbourne from 16-19 May 2012. The Congress will be held in conjunction with the 35th Annual Brain Impairment Congress for the Australian Society for the Study of Brain Impairment and the 20th ASM of the Australasian Faculty of Rehabilitation Medicine (RACP). Over 1500 delegates are expected to attend.
The Congress will be a forum for the presentation of international research, discovery and innovation in NeuroRehabilitation Medicine and provide a focal point for local, national and international discussion regarding the latest developments in all major sub groups with the field, including Traumatic Brain Injury, Multiple Sclerosis, Stroke, Parkinsons Disease, Post-Polio Syndrome and Neuro-Oncology
The Scientific Program will run over three days with a pre-congress day of practical workshops .The program will have morning and early afternoon plenary sessions followed by themed sessions with invited speakers and selected free paper presentations.
The invited presentations will focus on the theme of innovation and new directions in these areas. They will also cover updates in the understanding of the basic science of the condition and an evaluation of newer treatment options in the acute and rehabilitation settings which includes emerging techniques in the various therapy disciplines.
The Scientific Committee also aims to focus on the measurement of long and short-term outcomes in the evaluation of effectiveness of acute and sub-acute management in key topic areas. An additional topic will involve a discussion of the role and current use of Complementary Medicine in NeuroRehabilitation.

17–21 June 2012 16th International Congress of Parkinson's Disease and Movement Disorders

Dublin, Ireland

On behalf of The Movement Disorder Society, we are honored to formally invite you to attend the 16th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland, from June 17-21, 2012.

The 2012 International Congress will be held in The Convention Centre Dublin, designed by Kevin Roche. This is Ireland's world class, purpose built international conference and event venue. Prepare to experience a location like no other, right in the heart of Dublin (UNESCO City of Literature). We look forward to coming together to learn about the latest research and advancements, collaborate with colleagues and actively participate in the advancing field of Movement Disorders, all while enjoying the history, literature, sights, sounds, and tastes of ancient Dublin.

Dublin (from the Irish Gaelic An Dubh Linn meaning 'the black pool') was established as a Viking settlement on the River Liffey over 1,000 years ago. The Anglo-Norman and subsequent English invasions followed. During the Georgian period, when it was the second largest city in the British Empire, Dublin became an important European cultural centre. This rich and varied history has left an indelible mark on this colourful and atmospheric city. Today, Dublin is a bustling metropolis with a population of over 1.7 million. Home to over 100 different nationalities, it has a genuinely cosmopolitan feel and yet retains its own distinct culture, which is expressed in a love of literature, drama and traditional music.

We are delighted to welcome you to Dublin for the 16th International Congress and hope you will take the opportunity to be part of this exceptional Scientific Program. We promise an unparalleled learning opportunity.

11–12 October 2012 7th Brain Research Conference: Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction

New Orleans, USA

The ability to express light-sensitive membrane channels (optogenetics) and synthetic receptors (pharmacogenetics) in neurons is revolutionizing neuroscience. With these new approaches, investigators can control neuronal activity or signaling with unprecedented specificity and precision. These methods are within the reach of most investigators, and are replacing less selective techniques of electrical stimulation, lesions or pharmacologic manipulations. These approaches are not only a boon to basic researchers, but also have substantial potential for development of novel clinical treatments for a range of nervous system disorders. The 2-day meeting will feature the originators (Deisseroth, Roth and Conklin) as well as early adopters of these methods, validating their utility in understanding neural function and potential for treating neural dysfunction.

25–27 March 2013 AAAI 2013 Spring Symposium on Shikakeology: Designing Triggers for Behavior Change

Stanford, CA, USA

Shikake is a Japanese word that represents physical and/or psychological trigger for implicit or explicit behavior change to solve problems. The aim of this workshop is to gain a holistic understanding of Shikake, i.e.:

  • Shikake principles
  • Behavior change triggers
  • Sustained behavior change
  • Case studies
  • Approaches to design simple and complex Shikake

The merits of Shikakeological approach are summarized as four points; low expertise, low cost, wide range of target users, and long term continuous behavior changes. Developing a Shikake can be easier and less expensive than developing complicated engineering mechanism. These advantages allow people to use the Shikake approach to address immediate problems without requiring specific expertise. Another Shikake objective is to induce spontaneous behavior. When people feel controlled or forced by someone or something to do something, they never do that again. On the other hand, if people desire and enjoy changing their behavior, they would do it repeatedly. Shikake aims to change behavior through a continuous engagement and transformation process. The goal of Shikakeology is to codify the cause and effect of Shikake cases from physical and/or psychological points of view, and to establish a Shikake design methodology. To achieve this goal, this workshop invites Shikake studies to share the knowledge, methods, experiments and findings that demonstrate triggers that motivate people and lead to behavior changes.

23–26 May 2013 4th International Conference on Neuropathic Pain

Toronto, Canada

The Special Interest Group on Neuropathic Pain (NeuPSIG), of the International Association for the Study of Pain (IASP), is proud to announce its fourth international meeting. For more information on NeuPSIG please visit
The first three NeuPSIG meetings were held in Madrid, Spain, in 2004 , Germany in 2007 and Athens, Greece, in 2010. Since then, there have been many exciting new developments in science and in patient care. Updates on present evidence-based research and medicine will be covered by world-renowned experts. There will be ample time for discussion during the workshops.

3–6 June 2013 Drug Discovery & Therapy World Congress 2013

Boston, MA, USA

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.

22–24 June 2013 20th Annual International "Stress and Behavior" Neuroscience and Biopsychiatry Conference

New Orleans, LA, USA

An annual international event gathering scientists and psychiatrists from around the world to share an interest in stress-evoked brain disorders in both humans and animals.

4–9 August 2013 IJCNN 2013 : IEEE International Joint Conference on Neural Networks

Dallas, TX, USA

The International Joint Conference on Neural Networks is the premier international conference in the area of neural networks. IJCNN 2013 is organized by the International Neural Network Society (INNS), and sponsored jointly by INNS and the IEEE Computational Intelligence Society - the two leading professional organizations for researchers working in neural networks.

IJCNN 2013 will be held at the Fairmont Hotel in Dallas, Texas. It will feature invited plenary talks by world-renowned speakers in the areas of neural network theory and applications, computational neuroscience, robotics, and distributed intelligence. In addition to regular technical sessions with oral and poster presentations, the conference program will include special sessions, competitions, tutorials and workshops on topics of current interest.

8–11 December 2013 XX World Congress on Parkinson's Disease and Related Disorders

Geneva, Switzerland

The XX World Congress on Parkinson's Disease and Related Disorders is an innovative educational forum for learning about the latest research and discoveries in etiology, pathogenesis, potential diagnostic markers and treatment modalities of Parkinson’s Disease and its related disorders. This biennial event is internationally recognized for the scope of its program, which covers a wide range of topics and consists of the world’s preeminent experts. Being held in beautiful Geneva, this congress is sure to attract a large faculty of distinguished scientists, clinicians and allied health experts from Europe and around the world.

31 October–5 November 2015 WCN 2015

Santiago, Chile

The Chilean Society of Neurology, Psychiatry and Neurosurgery is pleased to invite you to the World Congress of Neurology on October 31 November 5, 2015. The meeting will be held in Santiago, one of the most attractive and dynamic cities to visit both in Latin America and the world. As always, the World Congress will be an opportunity for learning, exchanging experiences and meeting top international specialists in neurology. Because we are committed to address our colleagues expectations, please feel free to make suggestions for the WCN 2015 scientific and teaching programs by sending an email to
See you in
Santiago, October 31 November 5, 2015. To learn more, visit

22–24 November 2016 The 2016 Sleep Summit


Sleep is vital to our well-being, and disruptions to sleep are closely linked with serious health and mood problems, including depression, obesity and high blood pressure. Up to 20% of western populations report frequent sleep disruption but despite this high prevalence, an understanding of the pathophysiology underlying sleep disorders is lacking, as are effective treatment strategies. This event will discuss the latest research on primary parasomnias and dyssomnias, the effect of illness on sleep quality, and the role of sleep in growth and development.

Back to Top